Harv Virk
@harv-virk.bsky.social
OGA community, YCharOS UK, UK Reproducibilty Network, University of Leicester.
Respiratory Medicine.
NIHR ACL MRC New Investigator
Respiratory Medicine.
NIHR ACL MRC New Investigator
Reposted by Harv Virk
In Lifecycle Journal's publish-before-review model, research is published before undergoing evaluation. Published submissions are eligible for review by services including @oga-community.bsky.social, a nonprofit that evaluates research that relies on antibodies:
lifecyclejournal.org/evaluation-s...
lifecyclejournal.org/evaluation-s...
Lifecycle Journal | Adding trust to your research, from conception through completion
lifecyclejournal.org
April 1, 2025 at 1:29 PM
In Lifecycle Journal's publish-before-review model, research is published before undergoing evaluation. Published submissions are eligible for review by services including @oga-community.bsky.social, a nonprofit that evaluates research that relies on antibodies:
lifecyclejournal.org/evaluation-s...
lifecyclejournal.org/evaluation-s...
Reposted by Harv Virk
We're very pleased to publicly announce the winners of the 2025 Dorothy Bishop Prize, which celebrates the contributions of early career researchers working to promote #OpenResearch and improve #ResearchCulture.
Congratulations to:
- Annayah Prosser
- Michael Biddle
- Lewis Jones
#AcademicSky
Congratulations to:
- Annayah Prosser
- Michael Biddle
- Lewis Jones
#AcademicSky
Dorothy Bishop Prize Winners 2025 | UK Reproducibility Network
www.ukrn.org
March 28, 2025 at 10:58 AM
We're very pleased to publicly announce the winners of the 2025 Dorothy Bishop Prize, which celebrates the contributions of early career researchers working to promote #OpenResearch and improve #ResearchCulture.
Congratulations to:
- Annayah Prosser
- Michael Biddle
- Lewis Jones
#AcademicSky
Congratulations to:
- Annayah Prosser
- Michael Biddle
- Lewis Jones
#AcademicSky
Reposted by Harv Virk
Congratulations Michael Biddle for winning the @ukrepro.bsky.social Dorothy Bishop award for your contributions to #Open and #Reproducible research culture. We are so proud of all of the excellent work you have been leading!
March 21, 2025 at 3:42 PM
Congratulations Michael Biddle for winning the @ukrepro.bsky.social Dorothy Bishop award for your contributions to #Open and #Reproducible research culture. We are so proud of all of the excellent work you have been leading!
Reposted by Harv Virk
Congratulations Michael Biddle for your nomination for this award recognising contributions to #Open , #Reproducible , and generally better research!
www.ukrn.org/2025/03/04/d...
www.ukrn.org/2025/03/04/d...
DB Prize 2025 shortlisted nominees
www.ukrn.org
March 4, 2025 at 12:40 PM
Congratulations Michael Biddle for your nomination for this award recognising contributions to #Open , #Reproducible , and generally better research!
www.ukrn.org/2025/03/04/d...
www.ukrn.org/2025/03/04/d...
Reposted by Harv Virk
We’re pleased to join the UK Reproducibility Network (@ukrepro.bsky.social) as a stakeholder in support of a more open, transparent and reproducible research culture. Find out more:
UKRN welcomes eLife and Hidden REF as new stakeholders | UK Reproducibility Network
Feb 4, 2025 | News
www.ukrn.org
February 4, 2025 at 5:45 PM
We’re pleased to join the UK Reproducibility Network (@ukrepro.bsky.social) as a stakeholder in support of a more open, transparent and reproducible research culture. Find out more:
Reposted by Harv Virk
This rate of validation suggests that antibodies should be considered non-specific until proven otherwise:
357 validated out of 1,124 tested.
.
357 validated out of 1,124 tested.
.
January 31, 2025 at 12:24 PM
This rate of validation suggests that antibodies should be considered non-specific until proven otherwise:
357 validated out of 1,124 tested.
.
357 validated out of 1,124 tested.
.
January 28, 2025 at 5:11 PM
Reposted by Harv Virk
🚨 Just over 24 hours left for PhD applications to be submitted to join our DTP
📅 Midday (GMT) TOMORROW Friday 10 Jan
The application form and all details are on our website more.bham.ac.uk/mrc-aim/phd-... as well as a helpful FAQ doc and two Zoom recordings from recently held information sessions
📅 Midday (GMT) TOMORROW Friday 10 Jan
The application form and all details are on our website more.bham.ac.uk/mrc-aim/phd-... as well as a helpful FAQ doc and two Zoom recordings from recently held information sessions
🚨Exciting first post🚨
Applications now open for our fully funded Medical Research Council 4 year PhD studentships across our 3 partner institutions @unibirmingham.bsky.social University of Leicester and @uniofnottingham.bsky.social
We welcome applications from home and international candidates. 🧵
Applications now open for our fully funded Medical Research Council 4 year PhD studentships across our 3 partner institutions @unibirmingham.bsky.social University of Leicester and @uniofnottingham.bsky.social
We welcome applications from home and international candidates. 🧵
a blue sign that says " apply now " with an eagle
ALT: a blue sign that says " apply now " with an eagle
media.tenor.com
January 9, 2025 at 11:23 AM
🚨 Just over 24 hours left for PhD applications to be submitted to join our DTP
📅 Midday (GMT) TOMORROW Friday 10 Jan
The application form and all details are on our website more.bham.ac.uk/mrc-aim/phd-... as well as a helpful FAQ doc and two Zoom recordings from recently held information sessions
📅 Midday (GMT) TOMORROW Friday 10 Jan
The application form and all details are on our website more.bham.ac.uk/mrc-aim/phd-... as well as a helpful FAQ doc and two Zoom recordings from recently held information sessions
Reposted by Harv Virk
📣Check out "A Consensus Platform for Antibody Validation," which describes YCharOS's knockout cell-line based antibody validation platform. 📣
www.nature.com/artic...
www.nature.com/artic...
A consensus platform for antibody characterization
Nature Protocols - YCharOS is a consensus platform for antibody characterization developed through collaboration between academia and industry, enabling direct comparisons among antibodies that...
www.nature.com
December 20, 2024 at 5:04 PM
📣Check out "A Consensus Platform for Antibody Validation," which describes YCharOS's knockout cell-line based antibody validation platform. 📣
www.nature.com/artic...
www.nature.com/artic...
Reposted by Harv Virk
Better antibodies, Better science, Better patient outcomes. Visit us to find out more!
onlygoodantibodies.com/projects/
onlygoodantibodies.com/projects/
Our Projects - Only Good Antibodies Community
onlygoodantibodies.com
December 20, 2024 at 5:18 PM
Better antibodies, Better science, Better patient outcomes. Visit us to find out more!
onlygoodantibodies.com/projects/
onlygoodantibodies.com/projects/
Reposted by Harv Virk
Learn more about us and our collaboration with @ycharos.bsky.social in this @nature.com feature by Diana Kwon.
www.nature.com/articles/d41...
www.nature.com/articles/d41...
The antibodies don’t work! The race to rid labs of molecules that ruin experiments
Poorly performing antibodies have plagued biomedical sciences for decades. Several fresh initiatives hope to change this.
www.nature.com
December 20, 2024 at 5:24 PM
Learn more about us and our collaboration with @ycharos.bsky.social in this @nature.com feature by Diana Kwon.
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Reposted by Harv Virk
The @ycharos.bsky.social antibody characterization protocol using knock-out cells as controls is now published, and endorsed. Remember though that it’s a generic protocol - you still need to do the proper controls for your own experiments! www.nature.com/articles/s41...
YCharOS protocol for antibody validation - Nature Protocols
Poorly performing antibodies contribute to the reproducibility crisis in biomedical research. The market offers millions of antibodies and validating them is a cumbersome process. Now, the non-profit ...
www.nature.com
December 17, 2024 at 2:33 PM
The @ycharos.bsky.social antibody characterization protocol using knock-out cells as controls is now published, and endorsed. Remember though that it’s a generic protocol - you still need to do the proper controls for your own experiments! www.nature.com/articles/s41...